drugset / Trial / NCT03461081

Drug-drug Interaction Following Oral Administration of Telmisartan/Amlodipine and Atorvastatin in Healthy Adult Volunteers

NCT03461081

Phase 1 Completed 32 enrolled Jeil Pharmaceutical Co., Ltd.
RandomizedCrossoverOpen-labelTreatment

Summary

study to evaluate drug-drug interaction following oral administration of telmisartan/amlodipine and atorvastatin in healthy adult volunteers

Timeline

Start
2017-05-07
Primary completion
2017-07-12
Completion
2017-12-12

Drugs

EvaluationDrugModalityDoseRoute
Subject Amlodipine Other / unclassified 5 mg Oral
Subject Atorvastatin Small molecule 40 mg Oral
Subject Telmisartan Other / unclassified 40 mg Oral